These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 7617828

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changes induced by sodium cromoglycate on brain serotonin turnover in morphine dependent and abstinent mice.
    San-Martin-Clark O, Leza JC, Lizasoain I, Lorenzo P.
    Psychopharmacology (Berl); 1993; 111(2):233-8. PubMed ID: 7532863
    [Abstract] [Full Text] [Related]

  • 3. Effects of trepelennamine on brain monoamine turnover in morphine dependent and abstinent mice.
    San-Martin-Clark O, Cuellar B, Leza JC, Lizasoain I, Lorenzo P.
    Psychopharmacology (Berl); 1996 Feb; 123(3):297-302. PubMed ID: 8833423
    [Abstract] [Full Text] [Related]

  • 4. Effects of naloxone-precipitated withdrawal after a single dose of morphine on catecholamine concentrations in guinea-pig brain.
    Brent PJ, Chahl LA.
    Neurochem Res; 1991 May; 16(5):525-31. PubMed ID: 1754029
    [Abstract] [Full Text] [Related]

  • 5. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism.
    Karoum F, Suddath RL, Wyatt RJ.
    Eur J Pharmacol; 1990 Sep 04; 186(1):1-8. PubMed ID: 2282931
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F, Korpi ER, Linnoila M, Chuang LW, Wyatt RJ.
    Eur J Pharmacol; 1984 Apr 20; 100(2):137-44. PubMed ID: 6234178
    [Abstract] [Full Text] [Related]

  • 8. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
    Fuertes G, Laorden ML, Milanés MV.
    Neuroendocrinology; 2000 Jan 20; 71(1):60-7. PubMed ID: 10644900
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a peripheral mechanism in cardiac opioid withdrawal.
    Milanés MV, Martinez MD, González-Cuello A, Laorden ML.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep 20; 364(3):193-8. PubMed ID: 11521160
    [Abstract] [Full Text] [Related]

  • 10. A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
    Tokuyama S, Ho IK, Yamamoto T.
    Brain Res Bull; 2000 Jul 15; 52(5):363-9. PubMed ID: 10922515
    [Abstract] [Full Text] [Related]

  • 11. Catecholamine utilization in distinct mouse brain nuclei during acute morphine treatment, morphine tolerance and withdrawal syndrome.
    Kovács GL, Acsai L, Tihanyi A, Telegdy G.
    Eur J Pharmacol; 1983 Sep 30; 93(3-4):149-58. PubMed ID: 6685650
    [Abstract] [Full Text] [Related]

  • 12. Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
    Tokuyama S, Ho IK.
    Psychopharmacology (Berl); 1996 May 30; 125(2):135-40. PubMed ID: 8783387
    [Abstract] [Full Text] [Related]

  • 13. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.
    Dunn AJ, Berridge CW.
    Pharmacol Biochem Behav; 1987 Aug 30; 27(4):685-91. PubMed ID: 2443934
    [Abstract] [Full Text] [Related]

  • 14. Baclofen reestablishes striatal and cortical dopamine concentrations during naloxone-precipitated withdrawal.
    Diaz SL, Kemmling AK, Balerio GN.
    Neurochem Int; 2003 Mar 30; 42(4):293-8. PubMed ID: 12470702
    [Abstract] [Full Text] [Related]

  • 15. Brain catecholamine metabolites and behavior in morphine withdrawal.
    Swann AC, Elsworth JD, Charney DS, Jablons DM, Roth RH, Redmond DE, Maas JW.
    Eur J Pharmacol; 1982 Dec 24; 86(2):167-75. PubMed ID: 6297931
    [Abstract] [Full Text] [Related]

  • 16. Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions.
    Gottberg E, Grondin L, Reader TA.
    J Neurosci Res; 1989 Mar 24; 22(3):338-45. PubMed ID: 2709448
    [Abstract] [Full Text] [Related]

  • 17. Effects of urapidil on catecholamine turnover and release in the central nervous system of the rat.
    Singer EA, Cichini G, Valenta B, Kraupp O.
    J Pharm Pharmacol; 1989 Mar 24; 41(3):173-8. PubMed ID: 2568444
    [Abstract] [Full Text] [Related]

  • 18. Changes in striatal dopamine metabolism during the development of morphine physical dependence in rats: observations using in vivo microdialysis.
    Schrater PR, Russo AC, Stanton TL, Newman JR, Rodriguez LM, Beckman AL.
    Life Sci; 1993 Mar 24; 52(19):1535-45. PubMed ID: 8483382
    [Abstract] [Full Text] [Related]

  • 19. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
    Hallman H, Jonsson G.
    Med Biol; 1984 Mar 24; 62(3):198-209. PubMed ID: 6492900
    [Abstract] [Full Text] [Related]

  • 20. The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment.
    Airio J, Ahtee L.
    Br J Pharmacol; 1999 Apr 24; 126(7):1609-19. PubMed ID: 10323593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.